EPISODE · Jun 20, 2020 · 7 MIN
Oriahnn for Fibroids HMB (New Med Approval)
from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls
On May 29, 2020, the U.S. FDA approved an novel oral drug, Oriahnn, for HMB use to fibroids. This medication (elagolix, estradiol, and norethindrone acetate) is the first oral medication designed specifically for Fibroid HMB. In this session, we will review this new medication. (No financial disclosures to report).
Embed this episode
NOW PLAYING
Oriahnn for Fibroids HMB (New Med Approval)
0:00
7:15
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?
This episode is 7 minutes long.
When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?
This episode was published on June 20, 2020.
Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!